SEC CIK 1131399

GLAXOSMITHKLINE PLC

Reported ownership across 19 companies, sourced from SEC Form 4 filings and updated daily.

Current Positions

CompanyShares OwnedAs Of
LYELview stock →30,253,1892021-06-21
WVEview stock →18,245,6912025-12-11
PGNYview stock →6,238,2442020-05-20
GNCAview stock →4,626,3892020-07-24
TBIOview stock →3,697,9122018-07-02
NKTXview stock →3,150,7322020-07-14
PRNBview stock →2,982,8552019-10-18
MORFview stock →2,633,7722019-07-01
TPTXview stock →2,253,6602020-05-21
PANDview stock →2,248,3042020-07-21
SPROview stock →1,934,0062018-07-17
BCYCview stock →1,910,5312020-07-15
FULCview stock →1,785,7142019-07-22
DBTXview stock →1,183,6632021-02-17
CVRXview stock →1,007,5832021-07-02
LQDAview stock →624,4222018-07-30
CCXIview stock →02018-10-16
INVAview stock →02021-05-20
TBPHview stock →02022-09-16

Position History — NKTX

Reported shares owned immediately after each Form 4 transaction, over time.

01,050,2442,100,4883,150,7322020-072020-072020-072020-07

Recent Filings — NKTX

DateActivitySharesPriceOwned After
2020-07-14Grant / award (derivative)10,700$0.0010,700
2020-07-14Conversion (derivative)6,337,403—0
2020-07-14Conversion (derivative)292,663—0
2020-07-14Open-market buy833,333$18.003,150,732
2020-07-14Conversion1,712,810—2,317,399
2020-07-14Conversion525,499—604,589
2020-07-14Conversion79,090—79,090

Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.